Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-011292

Chief Development Officer sold 176 shares at $10.22 ($1,799)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Michaelson Jennifer Chief Development Officer 2023-04-12 Sale −176 $10.22 $1,799 91,117 D: show line 1 in the form
Open-market sales · 176 sh · avg $10.22 · $1,799
Loading xslF345X04/doc4.xml…